Search
CELL BANK Website

Back Back
Cell No. : Cell Name
RCB1840 : MVP49  update : 2022/04/07
CommentHybridoma producing a monoclonal antibody against Medaka Vitellogenin.
Comment from the depositor
Terms and conditionsThere is no restriction regarding use for basic researches. In relation to commercial use and use for patent filing, first of all please contact the RIKEN BRC.
Remarks
Order Form Order Form(C-0005.pdf)   Approval Form(C-0006.pdf)   MTA(C-0007.pdf)   MTA(C-0007p.pdf)  
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
Basic information Depositor Shiraishi, Hiroaki
Originator Shiraishi, Hiroaki
Year of deposit 2002
Animal mouse x mouse < Hybrid
Tissue hybridoma
Classification hybrid cells
Lifespan infinite
Morphology lymphocyte-like
Cellosaurus(Expasy) CVCL_U133
hybridoma Fusion_cell_1 name P3U1
Fusion_cell_1 strain mouse
Fusion_cell_2 name spleen
Fusion_cell_2 strain mouse, BALB/c
Fusion method PEG, HAT selection
Antibody name MVP49
Subclass IgG1
Immunogen Medaka Vitellogenin
Antigen_name Medaka Vitellogenin
Antigen_m.w. 196k
Antigen_epitope lipovitellin heavy chain
Antigen_positive Madaka female (ovary, liver, blood)
Antigen_negative Medamka male
deposit info
lot info
Medium Medium List
Culture type Suspension cells
Medium and additives RPMI1640 + 15% FBS + HAT
Antibiotics Free
Passage method dilution
Culture information Passage ratio 1 : 10 split
SC frequency Subculture : 2 times/week
Temperature 37 ℃
CO2 concentration 5 %
Freeze medium Medium + 10% DMSO
Freezing method Slow freezing
Mycoplasma (-)
Antibody subclass IgG1
Reference information Reference 0
User's Publication 0


To topTop
Reference

To topTop
User's Publication



Back Back Return Top Page